Literature DB >> 11068939

Somatostatin and somatostatin receptors in retinal diseases.

P M van Hagen1, G S Baarsma, C M Mooy, E M Ercoskan, E ter Averst, L J Hofland, S W Lamberts, R W Kuijpers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11068939     DOI： 10.1530/eje.0.143s043

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  10 in total

1.  The effect of octreotide against oxidative damage in photosensitized conjunctiva and cornea of rabbits.

Authors:  Ulkü Demir; Tamer Demir; Nusret Akpolat
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

2.  Vitreous levels of somatostatin in patients with chronic uveitic macular oedema.

Authors:  A Fonollosa; E Coronado; R Catalan; M Gutierrez; C Macia; M A Zapata; N Martinez-Alday; R Simo; J Garcia-Arumi
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

Review 3.  Somatostatin receptors and their interest in diagnostic pathology.

Authors:  Marco Volante; Francesca Bozzalla-Cassione; Mauro Papotti
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 4.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17

5.  The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease.

Authors:  Gerasimos E Krassas; Themistoklis Tzotzas; Konstantinos Papazisis; Kaliopi Pazaitou-Panayiotou; Kostas Boboridis
Journal:  Clin Ophthalmol       Date:  2007-09

Review 6.  Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas.

Authors:  Annamaria Colao; Mariagiovanna Filippella; Carolina Di Somma; Simona Manzi; Francesca Rota; Rosario Pivonello; Maria Gaccione; Michele De Rosa; Gaetano Lombardi
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 7.  Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.

Authors:  Cristina Hernández; Olga Simó-Servat; Rafael Simó
Journal:  Endocrine       Date:  2014-03-14       Impact factor: 3.633

Review 8.  Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.

Authors:  Robert Gábriel; Etelka Pöstyéni; Viktória Dénes
Journal:  Front Neurosci       Date:  2019-10-09       Impact factor: 4.677

9.  PACAP for Retinal Health: Model for Cellular Aging and Rescue.

Authors:  Etelka Pöstyéni; Andrea Kovács-Valasek; Viktória Dénes; Adrienn Mester; György Sétáló; Róbert Gábriel
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

10.  Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation.

Authors:  Esther Carrasco; Cristina Hernández; Inés de Torres; Jaume Farrés; Rafael Simó
Journal:  Mol Vis       Date:  2008-08-15       Impact factor: 2.367
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.